Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Vascular Surgery

Free Subscription Articles published in Thromb Haemost Retrieve available abstracts of 40 articles: HTML format Text format

Single Articles

July 2017
1. HARADA Y, Michel J, Lohaus R, Mayer K, et al
   Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents.
   Thromb Haemost. 2017;117.
   PubMed     Text format     Abstract available
   
   
   
2. SILLER-MATULA J, Lang IM, Schoergenhofer C, Roest M, et al
   Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary intervention.
   Thromb Haemost. 2017;117.
   PubMed     Text format     Abstract available
   
   
   June 2017
3. CUBEDO J, Blasco A, Padro T, Ramaiola I, et al
   Molecular signature of coronary stent thrombosis: oxidative stress and innate immunity cells.
   Thromb Haemost. 2017;117.
   PubMed     Text format     Abstract available
   
   
   May 2017
4. SEREBRUANY VL, Kim MH, Cabrera-Fuentes HA, Lee K, et al
   Mortality and cancer after 12 versus 30 months dual antiplatelet therapy. The Korean Outcomes Registry Evaluating Antithrombotics (KOREA).
   Thromb Haemost. 2017;117:934-939.
   PubMed     Text format     Abstract available
   
   
   March 2017
5. CAMPO G, Vieceli Dalla Sega F, Pavasini R, Aquila G, et al
   Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease.
   Thromb Haemost. 2017 Mar 23. doi: 10.1160/TH16-12-0973.
   PubMed     Text format     Abstract available
   
   
   February 2017
6. CHRISTOPOULOS C, Farag M, Sullivan K, Wellsted D, et al
   Impaired thrombolytic status predicts adverse cardiac events in patients undergoing primary percutaneous coronary intervention.
   Thromb Haemost. 2017;117:457-470.
   PubMed     Text format     Abstract available
   
   
   
7. BIANCARI F, Brascia D, Onorati F, Reichart D, et al
   Prediction of severe bleeding after coronary surgery: the WILL-BLEED Risk Score.
   Thromb Haemost. 2017;117:445-456.
   PubMed     Text format     Abstract available
   
   
   
8. URBANSKI K, Ludew D, Filip G, Filip M, et al
   CD14+CD16++ "nonclassical" monocytes are associated with endothelial dysfunction in patients with coronary artery disease.
   Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-08-0614.
   PubMed     Text format     Abstract available
   
   
   
9. FREYNHOFER MK, Iliev L, Bruno V, Rohla M, et al
   Platelet turnover predicts outcome after coronary intervention.
   Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-10-0785.
   PubMed     Text format     Abstract available
   
   
   
10. PARK Y, Tantry US, Koh JS, Ahn JH, et al
    Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial.
    Thromb Haemost. 2017 Feb 2. doi: 10.1160/TH16-10-0744.
    PubMed     Text format     Abstract available
    
    
    October 2016
11. FLIERL U, Zauner F, Sieweke JT, Berliner C, et al
    Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction.
    Thromb Haemost. 2016;117.
    PubMed     Text format     Abstract available
    
    
    September 2016
12. SIBBING D, Aradi D, Jacobshagen C, Gross L, et al
    A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on chronic Antiplatelet Treatment for Acute Coronary Syndr
    Thromb Haemost. 2016;117.
    PubMed     Text format     Abstract available
    
    
    June 2016
13. MEESTERS MI, Veerhoek D, de Lange F, de Vries JW, et al
    Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Thromb Haemost. 2016;116.
    PubMed     Text format     Abstract available
    
    
    March 2016
14. GREMMEL T, Ay C, Riedl J, Kopp CW, et al
    Platelet-specific markers are associated with monocyte-platelet aggregate formation and thrombin generation potential in advanced atherosclerosis.
    Thromb Haemost. 2016;115:615-21.
    PubMed     Text format     Abstract available
    
    
    January 2016
15. STEPPICH B, Hadamitzky M, Ibrahim T, Groha P, et al
    Stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute myocardial infarction. Long-term results of the REVIVAL-2 trial.
    Thromb Haemost. 2016;115.
    PubMed     Text format     Abstract available
    
    
    
16. KIM JS, Han DC, Jeong YH, Park DW, et al
    Antiplatelet effect of ticagrelor compared to tirofiban in non-ST-segment elevation ACS patients undergoing PCI. The result of the TE-CLOT trial.
    Thromb Haemost. 2016;115:213-21.
    PubMed     Text format     Abstract available
    
    
    
17. ASHER E, Fefer P, Sabbag A, Herscovici R, et al
    Prior chronic clopidogrel therapy is associated with increased adverse events and early stent thrombosis.
    Thromb Haemost. 2016;115:433-8.
    PubMed     Text format     Abstract available
    
    
    
18. VERGALLO R, Aguirre AD, Abtahian F, Minami Y, et al
    Recurrent myocardial infarctions and premature coronary atherosclerosis in a 23-year-old man with antiphospholipid syndrome.
    Thromb Haemost. 2016;115:237-9.
    PubMed     Text format    
    
    
    
19. COLLET JP, Kerneis M, Hulot JS, O'Connor SA, et al
    Point-of-care genetic profiling and/or platelet function testing in acute coronary syndrome.
    Thromb Haemost. 2016;115:382-91.
    PubMed     Text format     Abstract available
    
    
    
20. RUTTEN B, Roest M, McClellan EA, Sels JW, et al
    Platelet density per monocyte predicts adverse events in patients after percutaneous coronary intervention.
    Thromb Haemost. 2016;115:353-60.
    PubMed     Text format     Abstract available
    
    
    
21. DE STEFANO V, Qi X, Betti S, Rossi E, et al
    Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment.
    Thromb Haemost. 2016;115:240-9.
    PubMed     Text format     Abstract available
    
    
    August 2015
22. BONELLO L, Laine M, Camoin-Jau L, Noirot F, et al
    Onset of optimal P2Y12-ADP receptor blockade after ticagrelor and prasugrel intake in Non-ST elevation acute coronary syndrome.
    Thromb Haemost. 2015;114.
    PubMed     Text format     Abstract available
    
    
    
23. NUHRENBERG TG, Stratz C, Leggewie S, Hochholzer W, et al
    Temporal variability in the antiplatelet effects of clopidogrel and aspirin after elective drug-eluting stent implantation. An ADAPT-DES substudy.
    Thromb Haemost. 2015;114.
    PubMed     Text format     Abstract available
    
    
    
24. VRIES MJ, van der Meijden PE, Henskens YM, Ten Cate-Hoek AJ, et al
    Assessment of bleeding risk in patients with coronary artery disease on dual antiplatelet therapy. A systematic review.
    Thromb Haemost. 2015;114.
    PubMed     Text format     Abstract available
    
    
    June 2015
25. AMMI AY, Lindner JR, Zhao Y, Porter T, et al
    Efficacy and spatial distribution of ultrasound-mediated clot lysis in the absence of thrombolytics.
    Thromb Haemost. 2015;113:1357-69.
    PubMed     Text format     Abstract available
    
    
    May 2015
26. CAPODANNO D, Musumeci G, Lettieri C, Limbruno U, et al
    Impact of bridging with perioperative low-molecular-weight heparin on cardiac and bleeding outcomes of stented patients undergoing non-cardiac surgery.
    Thromb Haemost. 2015;114.
    PubMed     Text format     Abstract available
    
    
    April 2015
27. VRANCKX P, Leebeek FW, Tijssen JG, Koolen J, et al
    Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease. The XPLORER trial.
    Thromb Haemost. 2015;114.
    PubMed     Text format     Abstract available
    
    
    
28. CASAZZA F, Caponi C, Mignoli S
    A four-chamber in transit heart thrombus in a pregnant woman with acute pulmonary embolism.
    Thromb Haemost. 2015;114.
    PubMed     Text format    
    
    
    
29. DISTELMAIER K, Schrutka L, Seidl V, Winter MP, et al
    Pro-oxidant HDL predicts poor outcome in patients with ST-elevation acute coronary syndrome.
    Thromb Haemost. 2015;114.
    PubMed     Text format     Abstract available
    
    
    
30. CAPODANNO D, De Caterina R
    Bivalirudin for acute coronary syndromes: premises, promises and doubts.
    Thromb Haemost. 2015;113:698-707.
    PubMed     Text format     Abstract available
    
    
    
31. GREMMEL T, Koppensteiner R, Kaider A, Eichelberger B, et al
    Impact of variables of the P-selectin - P-selectin glycoprotein ligand-1 axis on leukocyte-platelet interactions in cardiovascular disease.
    Thromb Haemost. 2015;113:806-12.
    PubMed     Text format     Abstract available
    
    
    March 2015
32. KONSTANTINIDES SV, Warntges S
    Acute phase treatment of venous thromboembolism: advanced therapy. Systemic fibrinolysis and pharmacomechanical therapy.
    Thromb Haemost. 2015;113.
    PubMed     Text format     Abstract available
    
    
    
33. ZALEWSKI J, Bogaert J, Sadowski M, Woznicka O, et al
    Plasma fibrin clot phenotype independently affects intracoronary thrombus ultrastructure in patients with acute myocardial infarction.
    Thromb Haemost. 2015;113.
    PubMed     Text format     Abstract available
    
    
    
34. SIMSEKYILMAZ S, Liehn EA, Militaru C, Vogt F, et al
    Progress in interventional cardiology: challenges for the future.
    Thromb Haemost. 2015;113:464-72.
    PubMed     Text format     Abstract available
    
    
    
35. MENDOLICCHIO GL, Zavalloni D, Bacci M, Roveda M, et al
    Tailored antiplatelet therapy in a patient with ITP and clopidogrel resistance.
    Thromb Haemost. 2015;113:664-7.
    PubMed     Text format    
    
    
    February 2015
36. PICCOLO R, De Biase C, D'Anna C, Trimarco B, et al
    Early stent thrombosis with bivalirudin in patients undergoing percutaneous coronary intervention. A meta-analysis of randomised clinical trials.
    Thromb Haemost. 2015;113.
    PubMed     Text format     Abstract available
    
    
    
37. ARADI D, Collet JP, Mair J, Plebani M, et al
    Platelet function testing in acute cardiac care - is there a role for prediction or prevention of stent thrombosis and bleeding?
    Thromb Haemost. 2015;113:221-30.
    PubMed     Text format     Abstract available
    
    
    
38. KULKARNI K, Halton J, Spavor M, Israels SJ, et al
    Increased requirement for central venous catheter replacement in paediatric oncology patients with deep venous thrombosis: a multicentre study.
    Thromb Haemost. 2015;113:434-5.
    PubMed     Text format    
    
    
    November 2014
39. RADECKE CE, Warrick AE, Singh GD, Rogers J, et al
    Coronary artery endothelial cells and microparticles increase expression of VCAM-1 in myocardial infarction.
    Thromb Haemost. 2014;113.
    PubMed     Text format     Abstract available
    
    
    October 2014
40. ROSSINI R, Musumeci G, Capodanno D, Lettieri C, et al
    Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Results of a multicentre registry.
    Thromb Haemost. 2014;113.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: